SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0000950123-09-058099
Filing Date
2009-11-05
Accepted
2009-11-05 10:53:15
Documents
4
Period of Report
2009-11-05
Filing Date Changed
2009-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K g21077e8vk.htm 8-K 8422
2 EX-99.1 g21077exv99w1.htm EX-99.1 110129
3 GRAPHIC g21077g2107701.gif GRAPHIC 3819
4 GRAPHIC g21077g2107702.gif GRAPHIC 7046
  Complete submission text file 0000950123-09-058099.txt   135305
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

IRS No.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15875 | Film No.: 091160039
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1